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Neurogenesis in Xenopus neural ectoderm involves multiple gene families, including basic helix-loop-helix transcription
factors, which initiate and control primary neurogenesis. Equally important, though less well understood, are the
downstream effectors of the activity of these transcription factors. We have investigated the role of a candidate downstream
effector, Noelin-1, during Xenopus development. Noelin-1 is a secreted glycoprotein that likely forms large multiunit
complexes. In avians, overexpression of Noelin-1 causes prolonged and excessive neural crest migration. Our studies in
Xenopus reveal that this gene, while highly conserved in sequence, has a divergent function in primary neurogenesis.
Xenopus Noelin-1 is expressed mainly by postmitotic neurogenic tissues in the developing central and peripheral nervous
systems, first appearing after neural tube closure. Its expression is upregulated in ectopic locations upon overexpression of
the neurogenic genes X-ngnr-1 and XNeuroD. Noelin-1 expression in animal caps induces expression of neural markers
XBrn-3d and XNeuroD, and co-expression of secreted Noelin-1 with noggin amplifies noggin-induced expression of XBrn-3d
and XNeuroD. Furthermore, in animal caps neuralized by expression of noggin, co-expression of Noelin-1 causes expression
of neuronal differentiation markers several stages before neurogenesis normally occurs in this tissue. Finally, only secreted
forms of the protein can activate sensory marker expression, while all forms of the protein can induce early neurogenesis.
This suggests that the cellular localization of Noelin-1 may be important to its function. Thus, Noelin-1 represents a novel
secreted factor involved in neurogenesis. © 2001 Elsevier Science
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neural crest; placodes.INTRODUCTION
During nervous system development, a variety of cellular
interactions influence cell fate decisions. Neural induction
begins during gastrulation, when a region of mesodermal
tissue in amphibians called the Spemann Organizer invo-
lutes and comes to underlie the ectoderm, signaling it to
become neural (Spemann and Mangold, 1924; and see Lee
and Jessell, 1999; Weinstein and Hemmati-Brivanlou, 1999;
and Harland, 2000 for review). Antagonism of BMP signal-
ing by secreted factors such as Noggin, Chordin and Fol-
listatin plays a major role in allowing the ectoderm to form
neural tissue instead of epidermis (Lamb et al., 1993;
Hemmati-Brivanlou et al., 1994; Sasai et al., 1994; Piccolo
et al., 1996; Zimmerman et al., 1996; Fainsod et al., 1997).
Following initial induction, a neurogenic cascade of tran-
scription factors is activated which results in differentiation of
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340neurons within the neural field, and ultimately in the forma-
tion of the nervous system (reviewed in Anderson, 1995;
Chitnis, 1999). Basic helix-loop-helix (bHLH) transcription
factors of the achaete-scute and atonal families play an
important role in this process. The proneural bHLH genes
XASH-3 and X-ngnr-1 are expressed in the neural plate shortly
after gastrulation (Ferreiro et al., 1994; Ma et al., 1996).
Moreover, some bHLH genes have further roles in neuronal
development. For example, neurogenins have been shown to
have distinct neuronal cell-type inducing properties in the
cranial ganglia in addition to their roles in initiating neuro-
genesis (Ma et al., 1996; Fode et al., 1998; Ma et al., 1998;
Perez et al., 1999). In Xenopus, overexpression of X-ngnr-1
induces neurons of sensory character in the non-neural ecto-
derm, while in the eye it promotes development of specific
subtypes of retinal neurons (Olson et al., 1998; Perron et al.,
1999). In addition to the bHLH transcription factors, genes of
the Zinc finger and paired-domain families also are involved
in initiation of neurogenesis. The zinc finger transcription
factor NKL can promote neurogenesis in amphibian and chick
0012-1606/01 $35.00
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341Xenopus Noelin-1 Promotes Neurogenesisembryos (Lamar et al., 2001) and the paired-domain transcrip-
tion factor Pax-6 can direct neurogenesis of ectopic retina
(Chow et al., 1999).
While many types of transcription factors are known to
activate the programs of cell fate decisions in neural devel-
opment, the downstream effectors are complex and poorly
understood. Such genes exert their activities in a specific
context and are unable to initiate neurogenesis alone. An
example of such a molecule is Noelin-1, a secreted glyco-
protein expressed in the early neural plate of the chick
embryo (Barembaum et al., 2000).
Noelin isoforms were first identified in a screen of ran-
domly selected clones from a rat brain cDNA library (Daniel-
son et al., 1994). The protein sequences of Noelin-1 and -2
show similarity to that of Olfactomedin, an extracellular
matrix molecule thought to be involved in facilitating or
mediating odorant recognition (Snyder et al., 1991; Bal and
Anholt, 1993; Yokoe and Anholt, 1993). Four structurally
distinct messenger RNAs are spliced from the Noelin gene,
each sharing a common central exon (M), with two different 59
exons (A or B) added by differential promoter utilization, and
two different 39 exons (Y or Z) added by alternative splicing,
making up the four isoforms, BMZ, AMZ, BMY, and AMY
(Danielson et al., 1994), termed Noelin-1 through -4, respec-
tively (Barembaum et al., 2000). In mouse and rat, the four
Noelin isoforms are expressed at varying levels in the postna-
tal cortex (Danielson et al., 1994; Nagano et al., 1998). Differ-
ential expression of the four isoforms is found also in the
chick, where Noelin-1 and -2 are expressed during neurula
stages but Noelin-3 and -4 are not expressed until later
embryonic stages (Barembaum et al., 2000).
Previous studies from our lab have shown that avian
Noelin-1 is involved in the generation of neural crest cells
(Barembaum et al., 2000). To our knowledge, Noelin-1 is the
earliest marker of neural crest potential in the chick, preced-
ing the expression of other established neural crest markers
such as Slug (Nieto et al., 1994), AP-2 (Shen et al., 1997), and
Id2 (Martinsen and Bronner-Fraser, 1998). Avian Noelin-1 is
expressed from early stages in the neural plate and then is
subsequently limited to the neural folds and adjacent ecto-
derm, both tissues that have the potential to form neural crest
cells. Furthermore, retroviral overexpression of Noelin-1 in
avian embryos causes excessive and prolonged cranial neural
crest emigration, suggesting a role for Noelin-1 in neural crest
formation. Noelin-1 expression persists into later stages and is
observed in migrating neural crest cells and their derivatives
including cranial ganglia. It is also expressed in neurons in the
brain and spinal cord. This suggests that Noelin-1 protein
could also function in later steps of neural development in
addition to its earlier role in neural crest formation.
Here, we characterize the function of Noelin-1 in Xeno-
pus embryos. We describe the Xenopus homologs of
Noelin-1 and -2 and examine their roles during early ner-
vous system development. Interestingly, our studies reveal
temporal differences in expression of these transcripts be-
tween species that result in striking variations in their
utilization. Although chick Noelin-1 is involved in neural
© 2001 Elsevier Science. Acrest generation, Xenopus Noelin-1 appears to be involved
in promoting neuronal differentiation, suggesting that
Noelin isoforms may have been co-opted for different func-
tions in different vertebrates.
METHODS
Library Screening and cDNA Isolation
A stage 28 phage cDNA library in Lambda ZapII made from head
tissues was kindly provided by Dr. R. Harland (Hemmati-Brivanlou
et al., 1991). 1 3 106 plaque-forming units were screened with
chick Noelin-1 and a PCR fragment of the mouse Z exon. The
mouse subclone was generated by RT-PCR using upstream primer
59-CAG AAG GTG ATA ACC GG-39 and downstream primer
59-CAG CGC GCG GTC TTT AG-39 to amplify a 616 base pair (bp)
fragment of the Z exon from embryonic day 10 cDNA. Total RNA
was isolated by using RNAzol B (Tel-Test, Inc.) according to
manufacturer’s instructions. cDNA was synthesized using MMLV
Reverse Transcriptase (Roche). Full-length clones of Noelin-1, -2,
and -4 were obtained after low-stringency screening. Sequencing
was done by PCR using dye-terminators and run on an ABI Prism
automated sequencer. Sequences were compiled and edited using
the DNAstar programs. Sequences were compared to others in
GenBank by using BLAST (Altschul et al., 1990).
The largest open reading frame of the Noelin-1 cDNA (2862 bp
full length) is 1455 bp, running from nucleotide #327-1784 and
predicting a 485 amino acids (aa) protein with a molecular mass of
approximately 56 kD. Noelin-2 (2827 bp) coding sequence is
located between nucleotides #368-1744, predicting a 458 aa protein
with a molecular mass of approximately 53 kD. GenBank accession
numbers: Noelin-1 (AF416483) and Noelin-2 (AF416482).
Xenopus laevis Fertilizations, Dissections, and
Collection of Oocytes
Xenopus embryos were obtained by in vitro fertilization using
eggs from pigmented and albino females and testis from pigmented
males, according to established methods (Sive et al., 2000). Em-
bryos were staged according to the normal tables of Nieuwkoop and
Faber (1967).
Animal caps were manually isolated from stage 8–9 blastulae
and cultured in 3/4 X NAM (Slack and Forman, 1980) until siblings
reached stage 24 or 27 when they were fixed in MEMFA for 1 h and
then stored in 100% ethanol or processed for RT-PCR.
Xenopus ovaries were dissected from sexually mature females
through an abdominal incision after anesthetizing in Finquel’s
solution (Tricaine, Argent Chemical Laboratory). Ovaries were
rinsed in OR2 medium (Sive et al., 2000) and then stored at 14°C in
OR2 for up to 4 days. Stage VI oocytes were manually defolliculated
in OR2 with fine forceps and allowed to recover for one day before
injection. Oocytes that were in any way damaged by nicking or
tearing were discarded.
Microinjections
For oocytes: Capped messenger RNA was transcribed in vitro
(Sive et al., 2000) and 2 ng was injected per oocyte in a volume of
up to 20 nl. Oocytes were allowed to recover for 4 h before injection
of 4 mCi of 35S-methionine (Express Protein Labeling Mix, NEN) in
a volume that did not exceed 40 nl total. Injected oocytes were
ll rights reserved.
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oocytes. All samples were run in duplicate for each experiment.
For embryos: Capped messenger mRNA was transcribed as
above, or by using the mMessage mMachine SP6 kit (Ambion).
Varying concentrations were injected in volumes ranging from 5 to
10 nl at the two-cell stage, into both blastomeres for animal cap
experiments or into one cell of two for whole embryo experiments.
X-ngnr-1 was injected at 100 pg per embryo, XNeuroD was injected
at 500 pg per embryo. Noelin-1 or -2 were injected at a range from
50 pg-1.5 ng or as indicated in the text. Noggin was injected at a
range of 50–100 pg per embryo. Embryos were cultured until the
indicated stage in 0.1 X MMR and fixed for 1 h in MEMFA, then
stored in 100% ethanol until further use.
Immunoprecipitation
Oocyte and supernatant fractions were collected separately. The
oocytes were rinsed with 200 ml of OR2 to remove any secreted
material that might have adhered to the cell surface; this wash was
added to the supernatant fraction. Samples were quick-frozen at
280°C until further processing. In vitro translated protein was
synthesized using the same capped mRNAs in Nuclease-treated
Rabbit Reticulocyte Lysate (Promega) according to the manufac-
turer’s instructions.
The oocyte fraction was prepared for immunoprecipitation by
pipet trituration of 5 oocytes in 300 ml PBS 1 1% NP40 1
inhibitors (PBSNI; inhibitors: Aprotinin, Leupeptin, Pepstatin;
Sigma), centrifugation and then collection of the aqueous phase,
which was brought up to 750 ml with PBSNI. The supernatant
fraction was prepared for immunoprecipitation by bringing up to
750 ml with PBSNI. Anti-myc antibody (mouse monoclonal anti-
body 9E10, Santa Cruz Biotechnology) was used at 1:500 for 2 h at
4°C. Protein A Sepharose (Sigma) was incubated with the antibody-
treated samples for 1 h at 4°C with rocking; the sepharose beads
were then washed three times in PBSNI and resuspended in SDS
loading buffer. Samples were boiled for 5 min before loading on
8–12% SDS-polyacrylamide gels (Laemmli, 1970). Gels were fixed,
amplified with 1M Na-Salicylate (Sigma), dried and exposed over-
night at 280°C with an intensifying screen.
Deglycosylation was performed with Peptide-N-Glycosidase
(Promega) according to the manufacturer’s instructions. The en-
zyme is active in SDS sample buffer, so the reactions were done on
samples that were already prepared for loading.
Xenopus Noelin Constructs
The coding region of Noelin-1 was amplified using the following
PCR primers: upstream primer 59-CCA TCG ATC CAA GCA AAC
ATG TCT GTG CC-39; downstream primer 59-GCG GAT ATC
AAT TCA TCG GAT CG-39. Pwo polymerase (Roche) and low
cycle number (10 cycles of 94°C for 1 min, 55°C for 45 s, 72°C for
45 s) were used to minimize error introduction during amplifica-
tion. Restriction sites embedded in the primers were used to
subclone the 1.5 kb PCR product into the pCS2-mt expression
vector (Rupp et al., 1994; Turner and Weintraub, 1994) in which
five of the 6 myc tags were removed by the digestion with ClaI and
NcoI. In some constructs, we found that including six myc tags
prevented the protein from being secreted. The constructs were
verified to be in frame and without PCR-induced mutation by
sequencing.
© 2001 Elsevier Science. ATo subclone sequences encoding the amino acids SDEL or KDEL
at the amino terminus of these constructs, oligonucleotides
flanked by XhoI sites were synthesized (Integrated DNA Technolo-
gies) and treated with Polynucleotide Kinase (Roche) to add 59
phosphate groups. Duplex oligonucleotides were then prepared by
mixing at a 1:1 ratio of top and bottom strand oligos, denaturing at
95°C and cooling slowly to room temperature. Annealed oligo
duplexes were then ligated into the XhoI site in pCS21Noelin-1-mt
that occurs just after the myc tag. Oligo sequences were: SDEL top
strand: 59-TCG AGT CAG ATG AAC TGT AGC-39; SDEL bottom
strand: 59-TCG AGC TAC AGT TCA TCT GAC-39; KDEL top
strand: 59-TCG AGA AAG ATG AAC TGT AGC-39; KDEL bottom
strand: 59-TCG AGC TAC AGT TCA TCT TTC-39. Subclones
were verified to be in frame with the preceding Noelin-1-myc
region by sequencing.
DiI Injections
Vitelline membranes of early neurula embryos (stages 13–15)
were removed and embryos were allowed to recover in 1 X MMR
before injection at stage 17 with Cell Tracker CM DiI (Molecular
Probes). CM DiI was prepared by dissolving one tube in 10 ml of
100% ethanol, to which 90 ml of fresh 10% sucrose was then added.
The mixture was centrifuged prior to loading in the needle to
minimize clogging. Less than 3 nl was injected into several
positions along the neural folds, usually in three locations on each
side of the embryo. Embryos were cultured until approximately
stage 33 in 0.1 X MMR. Embryos were fixed in MEMPFA (fresh
paraformaldehyde improved DiI fixation) for 3–4 h to ensure that
the DiI was well fixed. This resulted in lower signal for in situ
hybridization, but fix time could be reduced although with some
loss of DiI signal.
In Situ Hybridization and Immunohistochemistry
In situ hybridization was performed as described in (Knecht et
al., 1995), except that only embryos hybridized to N-tubulin were
treated with RNAseA and T1 to eliminate signal in ciliated
epidermal cells. For sectioning, embryos were embedded in wax:
embryos were dehydrated to 100% ethanol, then washed 2 3 20
min in Histosol (National Diagnostics), 1 3 1 h Paraplast Plus wax
(Oxford) at 60°C, followed by an overnight incubation in wax.
Embryos were embedded in fresh wax and sectioned on a Leitz
microtome at 10 mm. Sections to be immunostained were dewaxed
and rehydrated, then stained with 1:500 anti-myc antibody (IgG;
9E10, Santa Cruz Biotechnology) or 1:1 HNK-1 supernatant (IgM;
American Type Culture Collection). The primary antibodies were
detected with Alexa 488 goat anti-mouse IgG or IgM (Molecular
Probes) as appropriate at 1:1000. Fluorescence and bright field
images were visualized on a Zeiss Axiophot and images were
captured on an Apogee digital camera.
RT-PCR Analysis
Pools of total RNA from 2 embryos or 10 animal caps were
isolated by Proteinase K treatment (ICN Pharmaceuticals; 250
mg/ml in 20 mM Tris, 100 mM NaCl, 30 mM EDTA, 1% SDS) for
1 h at 37°C. DNA was removed by treatment with RNAse-free
DNAse I (Roche) for 1 h at 37°C. First strand cDNA was synthe-
sized on RNA from 5 animal cap equivalents using Superscript II
Reverse Transcriptase (Life Technologies) with random hexamers
according to manufacturer’s instructions. The amount of cDNA
ll rights reserved.
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using a PhosphorImager and ImageQuant software (Molecular
Dynamics). All RNA samples were tested for genomic DNA
contamination in minus-reverse transcriptase reactions. The linear
ranges of amplification for each primer set was determined using
cDNA representing 0.005 of a whole embryo for each reaction
(roughly equivalent to 0.25 of one animal cap explant), at the stage
for which the animal caps were to be analyzed. PCR reactions were
performed in 1 X PCR buffer: 10 mM Tris–HCl pH 8.3, 1.5 mM
MgCl2, 50 mM KCl; with 0.5 mCi [a-32P]-dCTP, 100 mm each
nucleotide, 0.8 mm each primer and 1.5 units Taq polymerase.
Cycle conditions used were: (30 s at 94°C, 1 min at 55°C, 1 min at
72°C) for the cycle number indicated below; preceded by a 5 min
denaturation at 94°C and followed by a 6 min extension at 72°C.
One third of each reaction was run on a 5% polyacrylamide gel and
analyzed autoradiographically and on the PhosphorImager. PCR
primer sets and the cycle numbers used for each are listed below:
EF1a: (Agius et al., 2000); 221 nt; 20 cycles
U: 59-CCT GAA CCA CCC AGG CCA GAT TGG TG-39
D: 59-GAG GGT AGT CAG AGA AGC TCT CCA CG-39
Muscle actin: (Hemmati-Brivanlou and Melton, 1994); 222 nt; 23
cycles
U: 59-GCT GAC AGA ATG CAG AAG-39
D: 59-TTG CTT GGA GGA GTG TGT-39
NCAM: (Hemmati-Brivanlou and Melton, 1994); 342 nt; 26
cycles
U: 59-CAC AGT TCC ACC AAA TGC-39
D: 59-GGA ATC AAG CGG TAC AGA-39
Otx2: (Sasai et al., 1995); 315 nt; 28 cycles
U: 59-GGA TGG ATT TGT TGC ACC AGT C-39
D: 59-CAC TCT CCG AGC TCA CTT CTC-39
En2: (Hemmati-Brivanlou and Melton, 1994); 302 nt; 28 cycles
U: 59-CGG AAT TCA TCA GGT CCG AGA TC-39
D: 59-GCG GAT CCT TTG AAG TGG TCG CG-39
Krox20: (Mariani and Harland, 1998); 323 nt; 30 cycles
U: 59-ATT CAG ATG AGC GGA GTG-39
D: 59-ATG TGC TCC AGG TCA CTT-39
HoxB9: (Hemmati-Brivanlou and Melton, 1994); 217; 28 cycles
U: 59-TAC TTA CGG GGC TTG GCT GGA-39
D: 59-AGC GTG TAA CCA GTT GGC TG-39
Synaptobrevin II: (Knecht et al., 1995); 307 nt; 30 cycles
U: 59-ATT TGT CTG TGC GCA GGT-39
D: 59-TTT AAG CCA CTC CCT GCT-39
NeuroD: (Lallier and DeSimone, 2000); 238 nt; 30 cycles
U: 59-GTG AAA TCC CAA TAG ACA CC-39
D: 59-TTC CCC ATA TCT AAA GGC AG-39
Primer set designed for this study:
XBrn3d: 277 nt; 28 cycles
U: 59-CAT CAC CCT TCT GTT TTA-39
D: 59-GGG TCT GTT TCA CTT TCA-39
RESULTS
Noelin-1 and -2 Sequence and Structure
Xenopus Noelin-1 and -2 were cloned from a tailbud stage
(stage 28, Nieuwkoop and Faber, 1967) head cDNA library.
These isoforms vary only in their differential usage of
upstream promoters, synthesizing BMZ (Noelin-1) or AMZ
(Noelin-2) (see Fig. 1A, boxed upper right for splicing
schematic of the four Noelin isoforms). The nucleotide and
© 2001 Elsevier Science. Apredicted protein sequences are shown in Fig. 1A. Noelin-1
and -2 both contain predicted signal peptides (red under-
lines), several N-linked glycosylation sites (black arrow-
heads), potential hyaluronate binding sites (black under-
lines), and a glycosaminoglycan initiation site (gray
underline). Noelin-1 and -2 proteins are approximately 92%
identical to the chick counterparts; the proteins are also
globally similar to Olfactomedin, with Noelin-2 being
slightly more related overall because of a shorter 59 exon
region that requires fewer gap insertions on the alignment.
Noelin-1 and -2 share approximately 29% overall identity
(44% similarity) to Olfactomedin.
Furthermore, the Noelin Z region contains an Olfactome-
din domain (yellow underline). Several important structural
features are conserved between Noelin and Olfactomedin in
this domain, including three glycosylation sites (arrow-
heads, Fig. 1A) and three spatially conserved cysteine resi-
dues, one within the Olfactomedin domain and two that lie
outside of the Olfactomedin domain (green asterisks in Figs.
1A and 1B). In Olfactomedin, these latter two residues may
form intermolecular disulfide bonds that create oligomers
in the extracellular matrix (Yokoe and Anholt, 1993).
The Olfactomedin-related family includes Noelin homo-
logues, MYOC/TIGR (Stone et al., 1997), and the
a-Latrotoxin receptor (Davletov et al., 1996); all are more
highly conserved in the Olfactomedin domain, and share
42–48% identity to Xenopus Noelin (Fig. 1B). Olfactomedin
has 32% identity within the Olfactomedin domain (51%
similarity) to Xenopus Noelin. An alignment of the Noelin
Olfactomedin domain with that of Olfactomedin and re-
lated proteins is shown in Fig. 1B. The presence of the
Olfactomedin domain and other regions of homology be-
tween Noelin and Olfactomedin suggest that the two may
share some features, such as extracellular location, glyco-
slyation, and polymerization.
Noelin-1 Is a Secreted Glycoprotein
The A and B regions of the Noelin isoforms contain
hydrophobic sequences at their amino termini (see Fig. 1A,
red underline). Such sequences can mediate either localiza-
tion in the cell membrane or secretion, depending upon
whether the signal is cleavable. A computer modeling
method (http://www.cbs.dtu.dk/services/SignalP; Nielsen
et al., 1997) predicts the translated sequences to be cleaved:
in the A region after residue #16 in the sequence TMA-MI;
and in the B region after residue #26 in the sequence
VLP-TN (see red arrowheads, Fig. 1A).
The carboxy terminus for Noelin-1 and -2 (Z region)
encodes the sequence Ser-Asp-Glu-Leu (SDEL) that is simi-
lar but not identical to the consensus sequence Lys-Asp-
Glu-Leu (KDEL), the consensus sequence for protein reten-
tion in the endoplasmic reticulum (ER) of vertebrate,
Drosophila, Caenorhabditis elegans, and plant cells
(Munro and Pelham, 1987). Proteins containing the reten-
tion signal at their carboxy termini are selectively retrieved
ll rights reserved.
344 Moreno and Bronner-FraserFIG. 1. Sequence and Structure of Xenopus Noelin. A: Upper right corner box shows a schematic diagram for splice variants. The A (green)
and B (blue) exons are added by differential promoter utilization, M (yellow) is common to all four isoforms, Y (orange) and Z (red) are added
by alternative splicing. In the sequence portion of the figure, the A and B sequences are shown separately from the M-Z region, which is
shown as spliced. The deduced amino acid sequences of the Noelin exons are shown below nucleotide sequences. Both A and B regions
© 2001 Elsevier Science. All rights reserved.
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reside in the ER instead of being secreted along with
proteins that do not contain the signal. Previous authors
have described Noelins as ER-localized proteins based on
sequence interpretation and observation of immunostained
cells (Danielson et al., 1994; Nagano et al., 1998).
To determine whether the Noelin-1 putative signal pep-
tide is cleavable in vivo and whether the protein would be
retained in the ER, we performed in vivo secretion assays by
expressing Noelin-1 mRNA in Xenopus oocytes. Three
different single-myc tagged constructs of Noelin-1 were
prepared (see Fig. 2A schematic). Noelin-1-myc includes a
myc epitope at the carboxy terminus that blocks the endog-
enous Noelin SDEL sequence from any receptors. Noelin-
1-myc-SDEL contains the natural Noelin-1 carboxyl termi-
nal sequence subcloned after the myc tag, since any ER
retention signal must be available at the extreme carboxyl
terminus for binding to the retrieval receptors (Munro and
Pelham, 1987). Noelin-1-myc-KDEL includes the consensus
ER localization sequence after the myc tag. All three
constructs were synthesized using only a single myc tag as
it was found that including six myc tags inhibited the
secretion of Noelin-1 (data not shown).
The Noelin-1 constructs were microinjected into oocytes
with 35S-methionine and the oocyte and culture superna-
tant were analyzed by immunoprecipitation. After expres-
sion in Xenopus oocytes, Noelin-1-myc protein was ro-
bustly secreted. The secreted form of the protein appeared
as a high molecular weight complex [Fig. 2B, lane 3 arrow-
head, compare to core size in vitro translated (IVT) in lane
1]. This species, along with a smaller, specifically immuno-
precipitated band was recognized in oocyte fractions of
Noelin-1-myc injections (arrow, lane 2). We next tested
whether the sizes of the proteins in the oocyte and super-
natant fractions were larger than core size due to glycosyl-
ation, by treatment of the samples with a deglycosylating
enzyme. All specifically immunoprecipitated proteins in
the oocytes and supernatant (lanes 2 and 3) were reduced to
a core size (lanes 4 and 5) equivalent to that of in vitro
translated protein (IVT, lane 1), demonstrating that Noelin-
1-myc was glycosylated.
encode putative signal peptides (red underlines; predicted cleavage
potential sites for N-linked glycosylation throughout the sequen
potential hyaluronate binding sites in the common M region (blac
three cysteine residues that are conserved between Olfactomedin a
domain is indicated with a yellow underline. B: Xenopus Noelin
proteins and to Olfactomedin itself. Residues shaded in black are i
conserved between all other family members but not Olfactomed
marks conserved cysteine residue. Chick Noelin-1 (Barembaum et a
MYOC/TIGR (Nguyen et al., 1998), the a-latrotoxin receptor Latro
Olfactomedin, and a higher degree of similarity to each other than
42 and 48% identity to these proteins (90.4% to chick Noelin).
© 2001 Elsevier Science. ANoelin-1-myc-SDEL, which mimics the natural carboxy
terminal sequence of Noelin-1, was secreted but to a lesser
degree than Noelin-1-myc (Fig. 2C, arrowhead, lane 3). This
suggests that the endogenous SDEL sequence may act as a
suboptimal retrieval signal, allowing some of the protein to
be secreted but retaining a significant proportion within the
cell. As with Noelin-1-myc, the higher molecular weight
species was present in both the oocytes and the supernatant
of the Noelin-1-myc-SDEL construct (lanes 2 and 3, arrow-
head), while the intermediate form of the protein was
present only in the oocytes (lane 2, arrow). Additionally,
upon deglycosylation, the proteins collapsed to the pre-
dicted core size (lanes 4 and 5; IVT in lane 1).
As expected, the control construct Noelin-1-myc-KDEL
was not secreted (Fig. 2D), indicating that the oocytes
recognized the retention signal and properly retained this
protein. Importantly, oocytes expressing this construct did
not exhibit the higher molecular weight band that is char-
acteristic of the secreted constructs (see Fig. 2D lanes 2 and
3), but only contained the intermediate-size protein (arrow,
lane 2). This implies that the protein did not move far
enough through the Golgi apparatus to become as highly
glycosylated as the secreted constructs did, and provides
additional confirmation that the KDEL sequence caused all
of the protein to be retrieved to the ER while the SDEL
sequence did not. Deglycosylation of this sample collapsed
the band down to the core size (lane 4 compared to IVT in
lane 1). A secretion control sample using myc-tagged Nog-
gin showed that oocytes secreted and glycosylated this
construct as expected (Fig. 2F). The data show that the
Noelin-1 protein is glycosylated, contains a cleavable signal
sequence, and that the putative ER localization signal is not
sufficient to retain all of the protein within the ER.
To determine whether Noelin-1 protein could form large
complexes similar to those described for Olfactomedin, im-
munoprecipitated oocyte and supernatant samples were run
under nonreducing conditions. This allows intra and intermo-
lecular disulfide bridges to remain intact and reveals whether
protein complexes have formed. The complexes formed by
Noelin-1 in cultured oocytes and supernatant were so large
that they did not run through a 9% resolving gel, but rather
remained at the top, larger than the 200 kD molecular weight
depicted with a red arrowhead). Noelin isoforms contain several
6 sites for Noelin-2, and 7 for Noelin-1; black arrowheads), two
derline), a glycosaminoglycan initiation site (gray underline) and
oelin in the M and Z regions (green asterisks). The Olfactomedin
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346 Moreno and Bronner-Frasermarker, indicating the presence of high molecular weight
complexes (Fig. 2E, oocytes in lane 2, supernatant lane 3;
compare to IVT in lane 1). No proteins were specifically
immunoprecipitated in uninjected control oocytes or super-
natant (Fig. 2G). It is possible that the protein homopolymer-
FIG. 2. Oocyte secretion assay. Noelin-1 is secreted into the supern
along with 35S-methionine and oocyte and supernatant fractions we
reducing conditions except for E. A: Schematic diagram showing con
is SDEL, this is part of all three constructs but is blocked by the myc ta
subcloned 39 to the myc tag. B: Noelin-1-myc is robustly secreted fro
Oocytes contain an intermediate form of the protein that runs just s
protein runs at approximately 56 kD, the size predicted from the amin
secreted species are glycosylated, as treatment with peptide-N-glycosi
IVT sample [deglycosylated samples shown in lanes 4 (oocytes) and
endogenous carboxy terminal sequence SDEL is subcloned after the m
intermediate protein species (arrow, lane 2). As with the gel in (A
supernatant (arrowhead, lane 3). The proteins are highly glycosylated
(lanes 4 and 5). D: A Noelin-1 construct containing the consensus ER
sorting by oocytes. Noelin-1-myc-KDEL is not secreted and does not fo
Arrow in lane 2 marks the intermediate size protein found in all Noe
the Noelin-1-myc and Noelin-1-myc-SDEL constructs, deglycosylated
weight complexes that do not run into a 9% resolving gel under non
200kD. F: XNoggin-6myc is secreted as expected and is mildly glycos
cipitated protein from oocytes or supernatant. Numbers and bands d
markers of the indicated size. IVT, in vitro translated protein; o, oocy
deglycosylated supernatant fraction.izes by intermolecular disulfide bonding or that it forms
© 2001 Elsevier Science. Acomplexes with other proteins. Similar multimerization has
been observed for Olfactomedin in the extracellular matrix
(Yokoe and Anholt, 1993), suggesting this may be a conserved
feature of the two proteins. Thus, Noelin-1 is a secreted
glycoprotein that forms high molecular weight complexes in
when injected into oocytes. Myc-tagged constructs were co-injected
munoprecipitated with anti-myc antibody. All gels were run under
ts of Noelin-1 used in injections. Natural carboxy terminal sequence
s additional SDEL or KDEL-encoding oligonucleotide sequences were
e oocytes (lane 2), seen as the large band in the supernatant (lane 3).
r than the 69 kD marker (arrow in lane 2). In vitro translated (IVT)
d sequence (lane 1). The proteins made in the oocyte fraction and the
(PNGase) reduces the bands down to the core size comparable to the
upernatant)]. C: Oocytes secrete Noelin-1-myc-SDEL, in which the
ag, but at a lower level than Noelin-1-myc. Oocytes also contain the
y the largest species of protein in the oocytes is secreted into the
treatment with PNGase reduces all species to the core protein size
tion signal at the carboxy terminal was tested to verify proper protein
e higher molecular weight species found in the secretable constructs.
injected oocytes. This intermediate-size protein is glycosylated as in
ple is shown in lane 4. E: Noelin-1-myc protein forms high molecular
ing conditions. The species present in these samples are larger than
d. G: Uninjected oocyte controls contain no specifically immunopre-
at the left of each gel correspond the positions of molecular weight
ction; s, supernatant fraction; od, deglycosylated oocyte fraction; sd,atant
re im
struc
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347Xenopus Noelin-1 Promotes NeurogenesisExpression Pattern of Xenopus Noelin-1 and -2
Xenopus Noelin isoforms 1 and 2 were present in a stage
28 library from which they were isolated; expressed se-
quence tags containing the Z exon have also been found in
a Xenopus oocyte cDNA library (GenBank accession num-
bers AW199780 and AW199284). To characterize the ex-
pression of Noelin-1 and -2 in greater detail, in situ hybrid-
ization using the A, B, and Z exons was performed (see Fig.
1A box for isoform schematic). Signal from the A exon
alone, (found in Noelin-2 and -4) or the B exon alone (found
in Noelin-1 and -3) was always present wherever Z expres-
sion was found, suggesting that Noelin-1 and -2 have
identical expression patterns. Therefore we used the Z exon
to represent the expression patterns of both Noelin-1 and -2.
Expression of the Y isoforms Noelin-3 and -4 will be
reported elsewhere.
Noelin-1 and -2 expression was predominantly observed
in neurogenic tissues (Fig. 3). The earliest transcript expres-
sion was seen just after neural tube closure at approxi-
mately stage 21. Positive cells were located in the spinal
cord and in the olfactory placode and profundal-trigeminal
regions of the developing cranial sensory ganglia (V, Fig.
3A). The neural tube did not express the Z exon in brain
regions, but signal was visible posteriorly as two punctate
stripes of positive cells along each side of the spinal cord
(Fig. 3A and E) that appeared to correlate with the segmen-
tal development of neurons (see Hartenstein, 1993). At
stage 27, the olfactory placode, Vth (trigeminal) and VIIth
(facial nerve and geniculate) ganglia, the pineal gland, and
cells of the spinal cord expressed the Z exon (Fig. 3B). By
stage 33, intense signal was found in these regions and in
the brain (Fig. 3C). By stage 35, the IXth and Xth ganglia also
expressed Noelin-1 and -2 (Fig. 3D). Also at stage 35, a few
cells expressed Noelin-1 and -2 in the branchial arches that
may be of neural crest origin (arrowhead, Fig. 3D). Within
the developing brain, Z exon transcripts were not detected
until stage 25 in a small number of medially located cells
that are likely to be interneurons (data not shown). With
increasing age, the signal in the brain became more wide-
spread and intense rostrally. No signal was observed in the
brain at stage 22 (Fig. 3E); however, staining extended into
the midbrain by stage 27 (Fig. 3F) and through the forebrain
by stage 33 (Fig. 3G).
We next examined the cranial expression of Noelin-1 and
-2 in sections. Some but not all cells in the pineal gland
expressed Noelin-1 and -2, with more than half of pineal
cells positive in some regions (Fig. 4A). In the PNS, the
trigeminal ganglia and olfactory placodes were the first
structures to express the Z exon at stage 21. At stage 35, all
of the cranial sensory ganglia expressed Noelin-1 and -2: Vth
and VIIth (trigeminal and facial nerve/geniculate ganglion,
Fig. 4C), VIIIth (facial-acoustic, Fig. 4B), IXth (glossopharyn-
geal, Figs. 4B and 4E), and Xth (vagal, see Fig. 3D). In
addition, cells in the retinal ganglion and inner nuclear
layers of the developing eye were stained (Fig. 4D).
© 2001 Elsevier Science. ACranial sensory ganglia are peripheral nervous system
(PNS) structures, many of which are comprised of both
epidermal placode- and cranial neural crest-derived cells.
Neurogenic placodes develop from the early ectoderm as
regional thickenings and contribute many neurons to the
cranial sensory ganglia (see Baker and Bronner-Fraser, 2001
for review). Noelin-1 and -2 did not mark the cranial
placodes themselves but only the ganglia that are derived
from them. It is difficult to discern whether Noelin-1 and -2
were expressed in lateral line ganglia in the head; in
Xenopus these ganglia are fused with the branchiomeric
nerves (see Schlosser and Northcutt, 2000).
To determine precisely which cells in the spinal cord
express Noelin-1 and -2, we examined transverse sections of
tailbud-stage embryos. Xenopus embryos develop a simple
primary nervous system before metamorphosis that directs
motor responses to sensory input. Three stripes of primary
neurons are found on each side of the neural plate and later
within the neural tube corresponding to motor, inter and
sensory neurons (reviewed in Chitnis, 1999). Within the
spinal cord, the Noelin-positive cells were found in the
marginal zone where neurons are beginning to differentiate
and not in the ventricular zone where undifferentiated
neuroblasts divide.
The earliest Noelin-1 and -2-positive cells found in the
spinal cord at stage 22 were in the proper position to form
interneurons, since Rohon-Beard cells (sensory neurons)
and motor neurons are located more dorsally and ventrally,
respectively, than the cells that contained Noelin tran-
scripts (data not shown). By stage 28, varying populations of
cells were positive for the Z exon at different levels of the
spinal cord; some sections revealed dorsal and intermediate
cells to be positive, while others showed intermediate and
ventral positive cells (arrowheads, Figs. 5A and 5C). The
carbohydrate epitope antibody HNK-1 recognizes neurons
in amphibian spinal cord (Nordlander, 1989); immunostain-
ing with this antibody showed co-localization of mRNA for
the Z exon and the antibody signal in these sections
(arrowheads, Figs. 5B and 5D). HNK-1 staining was gener-
ally found in wider regions than Noelin-1 and -2 transcripts,
indicating that Noelin-1 and -2 were not expressed by all
developing neurons at these stages. At stage 33, most cells
in the marginal zone of the ventral spinal cord were positive
for Noelin-1 and -2 (Fig. 5E). Furthermore, at stage 35, a
gradation of signal from dorsal to ventral was observed,
with dorsal expression being the strongest. Interestingly,
neural crest cells migrating into the fin were also found to
express Noelin-1 and -2 beginning at stage 35 (arrow,
Fig. 5F).
In contrast to the distribution pattern of the homologous
chick Noelin isoforms (Barembaum et al., 2000), Xenopus
Noelin-1 and -2 were not found in neural plate stages,
premigratory or migratory neural crest cells (except at fairly
late stages in the fin mesenchyme). Thus, the Xenopus
Noelin-1 and -2 expression pattern is similar to the later
ll rights reserved.
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early expression in neural tissues.
Origin of Noelin-Positive Cells in the Cranial
Ganglia
We next examined the population of cells in the cranial
sensory ganglia that express Noelin-1 and -2. Most of the
cranial sensory ganglia are made up of both placodal and
neural crest cells. Xenopus embryos contain two main
FIG. 3. Noelin-1 and –2 expression during development. Whole
distribution of Noelin-1 and Noelin-2 transcripts in the neural tube
A: Earliest expression is seen after neural tube closure in the spin
olfactory placodes and in the trigeminal (V) and geniculate (VII) gan
and spinal cord. C: A stage 33 embryo shows increasing signal in
population of cells in the retina is also positive for Noelin-1 and
transcripts. A small number of cells in the branchial arches express
22 embryo shows staining in the Vth ganglia and in the spinal cord.
marks the anterior extent of Noelin-1 and -2 signal in the neural tu
the level of the midbrain. The pineal gland and olfactory placodes a
ganglia, spinal cord, and more rostrally into the forebrain. e, eye; h
trigeminal; VII, geniculate; IX, glossopharyngeal; X, vagal; asteris
melanocytes in the skin or retinal pigmented epithelium in the eybodies of cranial neural crest cells, lateral and medial (see
© 2001 Elsevier Science. ASadaghiani and Thiebaud, 1987). The lateral neural crest
forms in large masses outside the boundary of the neural
plate, very close to the placodal ectoderm (see schematic,
pink region in Fig. 6A). These cells generally migrate as a
group, mainly contributing to distal derivatives in the
branchial arches (A. Collazo, C. LaBonne, M. B.-F., and S.
Fraser, in preparation). A smaller medial cranial neural crest
population exists as part of the neural folds relatively
distant from the placodes (red dots in Fig. 6A) and migrates
slightly later than the lateral crest cells, also contributing to
nt in situ hybridization with a probe to the Z exon reveals the
cranial ganglia. All embryos are oriented with anterior to the right.
rd and trigeminal ganglia at stage 22. B: By stage 27 cells in the
re strongly reactive. Punctate staining is visible in the pineal gland
th and VIIth ganglia, olfactory pits, pineal gland and spinal cord. A
: By stage 35/36 the IXth and Xth ganglia are also positive for the
Z exon (arrowhead). E-G: Dorsal views of embryos in A-C. E: Stage
scripts are not detected in the brain at this stage. The black arrow
: By stage 27, spinal cord staining extends into the brain and up to
ible. G: At stage 33 the signal is increasingly intense in the cranial
dbrain; o, olfactory placode/pit; p, pineal gland; sc, spinal cord; V,
ark the general position of otic vesicles. Brown color is due tomou
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al co
glia a
the V
-2. D
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b, hinthe cranial ganglia and other head structures.
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the cranial ganglia are derived from medial neural crest cells,
premigratory medial neural crest cells were labeled by focal
injection with DiI at stage 17, and the embryos were allowed
to develop to stage 33 when they were fixed and processed for
in situ hybridization with the Z exon. DiI-positive cells were
found in the neural tube, epidermal ectoderm and migrating
neural crest cells. Neural crest cells containing DiI were found
in the head mesenchyme, branchial arches and in the regions
surrounding cranial ganglia V, VII, VIII, and IX (see Fig. 6).
DiI-positive cells were found closely approximating the cra-
nial ganglia, but not mixed within the ganglia except in
sections that passed through their margins (data not shown).
To control for the possibility that placodal ectoderm was
inadvertently labeled, some embryos were fixed after a short
recovery period and processed for in situ hybridization against
Xenopus Brn-3r, a gene which is expressed in placodes and
sensory neurons of the cranial ganglia but not in neural crest
cells (O. Akin, M. B.-F., and C. LaBonne, in preparation), and
which has the same expression pattern as the closely-related
gene XBrn-3d (Hutcheson and Vetter, 2001). XBrn-3r expres-
sion did not overlap with DiI signal, showing that the placodes
were not labeled in these experiments (data not shown).
Transverse sections of DiI-labeled embryos hybridized to
the Z exon showed that the main bodies of the cranial
ganglia are strongly positive for Noelin-1 and -2 (Figs. 6B
and 6D). However, no DiI positive neural crest cells were
FIG. 4. Cranial expression of Noelin-1 and -2. 10 mm sections throug
a probe to the Z exon. A: A midbrain-region transverse section reveals
to the body of the gland, arrowhead denotes cells that are not positive f
signal in the VIIIth ganglion (arrow) and faintly in the IXth ganglion (arr
Vth and VIIth ganglia and the otic vesicle. The retinal ganglion cell la
through the eye reveals transcripts in the retinal ganglion cell layer an
layer, ciliary marginal zone or lens. E: A hindbrain section showing si
lens; mb, midbrain; rgc, retinal ganglion cell layer; V, trigeminal; V
asterisks denote otic vesicle; brown pigment is seen in melanocytesfound within this population (Figs. 6B–6C and 6D–6F).
© 2001 Elsevier Science. AInstead, the DiI-positive neural crest cells surrounded the
ganglia and failed to express Noelin-1 and -2. While we
cannot exclude the possibility that the earlier-migrating
lateral neural crest contributed cells to the ganglia that then
later expressed the Z exon, our data suggest that the
later-migrating medial neural crest cells probably contrib-
ute a greater amount of the neural crest proportion of the
cranial ganglia. These data indicate that later migrating
medial neural crest cells do not express Noelin-1 and -2 or
enter the ganglia at least before stage 33/34, and that
Noelin-1 and-2 expression at earlier stages is in placode-
derived ganglion cells.
Noelin-1 and -2 Are Up-Regulated by Neurogenic
Genes
Since the expression of Xenopus Noelin-1 and -2 isoforms
commences well after the time of neural induction and
since its distribution correlates with neuronal differentia-
tion, we examined whether Noelin-1 and -2 could be
downstream of the neurogenic cascade. The proneural gene
X-ngnr-1 (Ma et al., 1996) and the neural determination
gene XNeuroD (Lee et al., 1995) cause ectopic neurogenesis
in the non-neural ectoderm of embryos when they are over-
expressed. This ectopic neurogenesis induces N-tubulin
expression, among other neural and neuronal markers (Lee
et al., 1995; Ma et al., 1996).
d regions of a stage 35 embryo similar to that in Fig. 3D, stained with
lin-1 and -2-positive cells in the pineal gland and brain. Arrow points
elin-1 or -2. B: A hindbrain section at the midotic vesicle level shows
ad) ventral to the otic vesicle. C: Parasagittal section through the eye,
lso contains signal. D: A higher-power view of a transverse section
er nuclear layer, but not in the pigmented epithelium, photoreceptor
in the IXth ganglion. e, eye; hb, hindbrain; inl, inner nuclear layer; le,
ial nerve and geniculate; VIII, facial-acoustic; IX, glossopharyngeal;
etinal pigmented epithelium.h hea
Noe
or No
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gnalTo test whether Noelin-1 and -2 were downstream of
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X-ngnr-1 and then looked for effects on Noelin-1 and -2
expression by in situ hybridization. Noelin-1 and -2 were
dramatically up-regulated in the ectopic neurons that were
induced in the skin of embryos expressing these genes
(X-ngnr-1 effects shown in Figs. 7A and 7B). It is interesting
to note that in these experiments, sibling embryos express-
ing either neurogenic gene appeared to have a greater
number of ectopic N-tubulin-positive cells than Noelin-1 or
-2 positive cells, suggesting that Noelin-1 and -2 mark a
subset of the neurons induced by these neurogenic genes
(compare Fig. 7C with 7A and 7B).
Over-expression of X-ngnr-1 or XNeuroD also causes an
excess of neural tissue to form in the head. This tissue is
thought to differentiate early, thus bypassing normal pat-
terning in the region of ectopic expression. For example,
embryos overexpressing XNeuroD fail to form eyes in many
cases and do not express Pax-6 in the affected tissue (Hirsch
and Harris, 1997); while in sibling embryos, N-tubulin is
highly expressed. Upon examination with a probe to the Z
exon, we found that Noelin-1 and -2 were up-regulated in
regions of this extra tissue as well, further supporting a role
for this gene in neuronal differentiation (Fig. 7A).
We next examined whether Noelin-1 and –2 could be
directly activated by the neurogenic genes in the absence of
other tissue interactions by performing animal cap explant
experiments. Animal caps from late blastula stage embryos
are considered to be relatively naı¨ve ectoderm that will
differentiate into epidermis if cultured alone. We isolated
animal cap ectoderm from blastula-stage embryos overex-
pressing either X-ngnr-1 or XNeuroD, cultured the caps to
tailbud stages and then looked for expression of Noelin-1
and -2. It was previously shown that X-ngnr-1 and XNeuroD
induce neurogenesis directly (without mesoderm induc-
tion) in animal caps; X-ngnr-1 causes induction of
N-tubulin expression (Ma et al., 1996) and XNeuroD causes
induction of NCAM (Lee et al., 1995). In our experiments,
X-ngnr-1 and XNeuroD induced Noelin-1 and -2 expression
(Fig. 7D), but the response was quite weak compared to the
more robust induction that was seen for N-tubulin in the
animal cap explants (Fig. 7E) or for Noelin-1 and -2 and
N-tubulin in whole embryos expressing X-ngnr-1 (Figs. 7A
and 7B). Animal caps injected with b-galactosidase did not
express Noelin-1 and –2 (Fig. 7F) or N-tubulin (Fig. 7G).
Thus, Noelin-1 and -2 are responsive to neurogenic signals
but probably require input from other genes or inducers to
be highly expressed.
Noelin-1 Promotes Neurogenesis in a Neural
Context
We next examined the function of Noelin-1 and -2 by
overexpression, alone and in combination with other neu-
ralizing factors. Over-expression of either Noelin-1 or -2
alone had no obvious phenotype. Embryos injected with
varying doses in various locations did not display any overt
morphological perturbations. The size and location of the
© 2001 Elsevier Science. Amajor central nervous system structures such as brain, eye,
and spinal cord appeared normal. Neural crest-derived
branchial arches and melanocytes also appeared normal in
size, position and number. To show that the injected
mRNA produced protein that persisted to tailbud stages, we
performed immunohistochemistry for the myc epitope in
Noelin-1-myc-injected embryos and found that the protein
was expressed at least until stage 25 (data not shown). In
situ hybridization analysis with a panel of neural and neural
crest markers did not reveal any effects on marker gene
expression patterns for: (1) the pan-neural marker Sox-2
(Mizuseki et al., 1998); (2) the neuronal differentiation
marker N-tubulin (Oschwald et al., 1991); (3) the early
neural crest marker XSlug (Mayor et al., 1995); (4) later
neural crest marker XTwist (Hopwood et al., 1989); 5) the
sensory neuron marker for spinal cord and cranial ganglia
XBrn-3r (O. Akin, M. B.-F. and C. LaBonne, in preparation);
(6) the interneuron marker Pax-2 (Heller and Brandli, 1997);
or (7) Noelin-1 and -2 (data not shown).
We next tested whether Noelin-1 might function syner-
gistically with neuralizing factors. When exposed to the
BMP antagonist Noggin either by addition of protein or by
expression of noggin mRNA, animal caps are induced to
express the general neural marker NCAM and make tissue
characteristic of forebrain, expressing the marker Otx2
(Lamb et al., 1993). However, these explants do not express
general neuronal differentiation markers such as N-tubulin
or SynaptobrevinII until late tailbud/early tadpole stages,
reflecting the timing of neuronal differentiation in normal
embryos in which forebrain becomes positive for these
differentiation markers at around stage 33 (Lamb et al.,
1993; Ferreiro et al., 1994; Knecht et al., 1995; Papalopulu
and Kintner, 1996; Messenger et al., 1999; Lallier and
DeSimone, 2000).
Animal caps co-expressing both the neural inducer nog-
gin and Noelin-1 were cultured to stages 24 and 27. In
whole mount in situ hybridization assays, N-tubulin ex-
pression was activated by stage 24 in animal caps that were
expressing both noggin and Noelin-1, but not in explants
expressing either gene alone as shown in Figs. 8A and 8B.
Neurons differentiated in a scattered manner in the
Noelin-1 1 noggin animal caps, rather than converting the
entire explant into a neuronal domain (Fig. 8C). This effect
was reproduced in three separate experiments, with as few
as 50% of explants expressing N-tubulin (3/6 at stage 24)
and up to 82% (14/17) of explants expressing N-tubulin at
stage 27 (shown in Fig. 8). Thus, although Noelin-1 overex-
pression alone has no apparent phenotype, Noelin-1 pro-
motes early neurogenesis in animal cap tissue that has been
neuralized by noggin.
Noelin-1 Induces Early Differentation and Sensory
Neural Markers
To further investigate the role of Noelin-1 during neuro-
nal development, we examined relative levels of gene
expression in animal cap explants that were injected with
ll rights reserved.
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transcriptase polymerase chain reaction (RT-PCR) assays
on the explants. Noelin-1 1 noggin induced the neuronal
differentiation marker SynaptobrevinII (SybII, Knecht et
al., 1995) by stage 24 (Fig. 9A). This is consistent with our
findings of early neuronal differentiation based on in situ
hybridization results on whole animal caps with the
N-tubulin marker. Noelin-1 1 noggin did not induce ex-
pression of more posterior neural markers such as En-2
(expressed in the midbrain-hindbrain border, Hemmati-
Brivanlou et al., 1991), Krox-20 (hindbrain marker, Bradley
et al., 1993), or HoxB9 (spinal cord marker previously
known as XlhBox6, Wright et al., 1990) in the explants. In
contrast, Noelin-1 alone could induce Krox-20 and very low
levels of HoxB9 and the forebrain marker, Otx2 (Blitz and
Cho, 1995), whereas it was not sufficient to induce the
general early neural marker NCAM (Kintner and Melton,
1987), or En-2 expression. Therefore, the early neuronal
differentiation observed in Noelin-1 1 noggin animal caps
was not due to posteriorization of the forebrain-character
neural tissue that was induced by noggin, although alone
Noelin-1 expression of some posterior markers.
We next wished to determine whether secretion of
Noelin-1 was required for its function in promotion of
neuronal differentiation. Our in vivo secretion assay
showed that the endogenous form of Noelin-1 protein was
secreted, although a significant portion of the synthesized
protein remained within the oocyte fraction, probably in-
side the ER. We expressed Noelin-1-myc (a robustly se-
creted form), or Noelin-1-myc-KDEL (exclusively ER-
localized form), or the endogenous form of Noelin-1, with or
without noggin, to compare their activities in our animal
cap assay. Induction of early neuronal differentiation was
seen at stage 24 by activation of SybII expression from all
three constructs (Fig. 9B, SybII row, lanes 4, 6, 8); however,
the robustly secreted Noelin-1-myc caused the greatest
induction of SybII. Quantitation of the SybII data in Fig. 9B
revealed that Noelin-1 1 noggin or Noelin-1-myc-KDEL 1
noggin both caused a 2.4-fold induction of SybII expression
over noggin alone, and Noelin-1-myc 1 noggin caused a
3.3-fold induction over noggin alone. Thus, the highly
secreted construct of Noelin-1 was able to induce the
highest levels of SybII expression in the explants, though
this induction was only slightly greater than that produced
by the endogenous or nonsecreted forms of Noelin-1.
In contrast, the secreted forms (endogenous Noelin-1 and
Noelin-1-myc) both caused an upregulation of XBrn-3d in
the explants co-expressing noggin, while the nonsecreted
form did not (Fig. 9B, XBrn-3d row, lanes 4 and 6). Noggin
alone induced XBrn-3d to some degree (0.7 fold greater than
in control-injected animal caps; lanes 2 and 3), while
Noelin-1 1 noggin (lane 4) caused a 2.7-fold upregulation of
XBrn-3d over noggin alone, and Noelin-1-myc 1 noggin
(lane 6) caused a 3.4-fold upregulation. Noelin-1-myc-KDEL
1 noggin and Noelin-1-myc-KDEL did not induce XBrn-3d
expression as compared to noggin alone (compare lane 3
with 8 and 9). The secreted Noelin-1 constructs, when
© 2001 Elsevier Science. Aexpressed alone, induced XBrn-3d expression at levels com-
parable to that of noggin alone (lanes 5 and 7).
Interestingly, the well-secreted Noelin-1-myc induced
strong XNeuroD expression in the absence of neuralization
by noggin, while neither the endogenous Noelin-1 nor the
ER-localized form caused this response (lane 7). We also
found that expression of Noelin-1 alone, in any form, was
sufficient to activate expression of Krox-20 (Figs. 9A and 9B,
Krox-20 row lanes 5, 7, 9), with the secreted form being the
best inducer of this marker (lane 7). The ER-localized
construct did not have any activity that was not also
present in the secreted constructs. Furthermore, forced
secretion or ER localization of Noelin-1 did not change the
anterior/posterior character of noggin-induced neural tis-
sue. Noelin-1, whether retained within the ER or secreted
from the cell, promoted the early differentiation of neurons
and induce Krox-20 expression, but only the secreted forms
could induced the sensory marker XBrn-3d and XNeuroD.
Thus the secreted forms of Noelin-1 have added activities
that the ER-localized form does not, suggesting that endo-
genously, the localization of Noelin-1 may be an important
determinant of its function.
DISCUSSION
Noelin-1 Promotes Neurogenesis in Xenopus
Our findings suggest that Xenopus Noelin-1 is involved
in neurogenesis. Noelin-1 is a secreted glycoprotein that is
first expressed in developing neurons just after neural tube
closure, and activated by the neurogenic genes X-ngnr-1 and
XNeuroD. Noelin-1 itself has limited abilities to induce
certain neural markers, and in neuralized animal cap ex-
plants, Noelin-1 induces the expression of differentiated
neuronal markers much earlier than in the embryo or in
animal caps neuralized by noggin alone. These results
suggest a role for Noelin-1 in promotion of neurogenesis.
Developmental Role of Noelin-1
Chick Noelin-1 has a striking expression pattern that
correlates with the potential of ectodermal cells to later
form the neural crest (Barembaum et al., 2000). The corre-
lation of Noelin-1 expression with the potential to form
neural crest and its ability to prolong neural crest emigra-
tion in vivo are novel and intriguing properties of the
protein. Because Xenopus embryos are more easily manipu-
lated for functional studies of genes, we investigated the
possibility that Noelin-1 and -2 were conserved in Xenopus
and examined their roles in development. Our results reveal
some interesting similarities and differences in both expres-
sion pattern and function. Its secretion and general struc-
ture appear very similar in both species. However, while
Noelin-1 appears to function in promoting neural develop-
ment in both species, it is expressed later in Xenopus and,
in fact, too late to respond to neural crest induction as in
the chick. Instead, it seems to be expressed in response to
ll rights reserved.
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ronal differentiation program.
Olfactomedin and Related Genes
Noelin sequence is highly conserved among species, with
FIG. 5. Caudal expression of Noelin-1 and –2 and HNK-1 immu
Arrowheads mark neuron populations in the spinal cord that expr
interneurons. B: The same section stained with HNK-1 shows that
signal is quenched by the in situ reaction product. C: Stage 28 emb
of the same section as in C. E: Stage 33 spinal cord illustrates expand
neural crest cells migrating into the fin (arrow) expressing Noelin-1
cells are pigmented neural crest cells (melanocytes). no, notochord92% identity to its chick counterpart. Moreover, in the
© 2001 Elsevier Science. A“Olfactomedin domain” which is found in the carboxy-
terminal-half of the Z region (Barembaum et al., 2000;
Kulkarni et al., 2000), Noelin -1 and -2 proteins exhibit
approximately 51% similarity at the amino acid level to
Olfactomedin, a protein thought to be involved in facilitat-
ining. 10 mm sections through embryos stained with the Z exon.
e gene. A: Stage 28 embryo with signal in Rohon-Beard cells and
in marks only a subset of the neurons present. Some of the HNK-1
ith signal in interneurons and motor neurons. D: HNK-1 staining
omain of Noelin-1 and -2 expression. F: Stage 35 spinal cord shows
2. In E and F, black line demarcates the ventral neural tube. Brownnosta
ess th
Noel
ryo w
ing d
and -
.ing or mediating odorant recognition (Snyder et al., 1991).
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353Xenopus Noelin-1 Promotes NeurogenesisThe tertiary structure of Olfactomedin is predicted to be a
polymer of ordered Olfactomedin units that are covalently
linked by inter- and intramolecular disulfide bonds (Yokoe
and Anholt, 1993). In this model, the N-linked glycosyla-
tion sites are apposed to form a network of extracellular
matrix material. Noelin-1 and -2 homologs contain residues
in similar positions for disulfide bond formation and glyco-
sylation, suggesting that the tertiary structure could be
similar to Olfactomedin in this domain (Karavanich and
Anholt, 1998). Additionally, it is likely that in vivo, like
Olfactomedin, the proteins associate into large, high
FIG. 6. DiI labeling of premigratory medial neural crest. Noelin-1
stage 33 embryos with neural crest cells labeled by focal injections
was performed against the Z exon. A: Schematic diagram of a stage
placode domain (blue) and the medial neural crest which were labe
section at the caudal eye level, showing Noelin-1 and -2 expression
-2-positive. C: Fluorescent view of section in B, arrow marks DiI po
including the VIIth ganglia. Ganglion cells express Noelin-1 and -2
image of section in (D) shows DiI-positive cells surrounding, but no
Noelin negative; arrowhead marks a cell that is Noelin-1 and -2
nonoverlapping DiI and Noelin-1 and -2 cells. In both embryos (B-C
but do not appear to mix with the placodal cells at this stage. Ana
hb, hindbrain; mb, midbrain; V, Vth ganglion (trigeminal); VII, VIItmolecular-weight complexes based upon the large size of
© 2001 Elsevier Science. Athe recombinant proteins under nondenaturing SDS–PAGE
conditions. These observations, along with the suggestive
conservation of the Olfactomedin domain and disulfide-
bridge-forming cysteine residues, imply that the native
protein may form a part of the extracellular matrix of cells
in which it is made. Its role in promoting neurogenesis may
indicate that it acts as an extracellular signal.
In addition to the similarity to Olfactomedin, Noelin-1
and -2 also exhibit sequence similarity to several other
recently discovered proteins of diverse function and struc-
ture such as the open angle glaucoma locus GLC1A (Stone
-2 are expressed in the cranial ganglia. Transverse section through
I in the neural folds at stage 17. Whole mount in situ hybridization
mbryo illustrating relative locations of lateral neural crest (pink),
ith DiI (red dots, arrow). B: Bright field view of a stage 33 embryo
e Vth ganglion. The cells marked by the arrow are not Noelin-1 or
neural crest cells. D: Bright field view of a hindbrain level section
whead), migrating neural crest cells do not (arrow). E: Fluorescent
ed within the ganglion. Arrow marks a cell that is DiI positive and
ive and DiI negative. F: Overlay of the fluorescent image shows
-F), DiI positive neural crest cells surround the condensing ganglia
at later stages was not possible due to dilution of the DiI. e, eye;
glion, (facial nerve and geniculate).and
of Di
17 e
led w
in th
sitive
(arro
t mix
posit
and D
lysis
het al., 1997) also called TIGR by Nguyen et al., (1998) or
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354 Moreno and Bronner-FraserMyocilin by Kubota et al., (1997) and now designated
MYOC; and the black widow spider venom (a-latrotoxin)
receptor protein Latrophilin (Davletov et al., 1996) or CIRL
(calcium-independent receptor of a-latrotoxin, Krasnoperov
et al., 1997). These proteins also contain the Olfactomedin
domain, as do several unidentified EST sequences (Kulkarni
et al., 2000). Currently, there are no data on the function of
the Olfactomedin domain.
Comparison of Noelin Expression Patterns
In early chick embryos, Noelin-1 mRNA is distributed
throughout the neural plate but is excluded from the
midline. At later stages of development, it becomes progres-
sively restricted to the tissues that are capable of giving rise
to neural crest cells: the neural folds, the dorsal neural tube,
and finally the premigratory and migratory crest. Chick
Noelin-1 mRNA is also found in the cranial placodes, cells
of the spinal cord and brain, and anterior regions of the limb
bud. This expression pattern is due to two separate isoforms
of Noelin, with one differentially expressed isoform
(Noelin-1) found in the neural crest at early stages and the
other (Noelin-2) found in the early placodal ectoderm; later
in development their expression patterns overlap (Barem-
baum et al., 2000). Although homologues of Noelin have
also been isolated from rat (Danielson et al., 1994) and
mouse (Nagano et al., 1998), their early embryonic expres-
sion in these species was not documented.
In contrast to the chick, Xenopus Noelin-1 and -2 have a
later onset of expression correlating with early neurogen-
esis in the cranial ganglia, eye, brain, and neurons of the
spinal cord. Expression is also found in the pineal gland. In
the cranial ganglia and spinal cord, the onset of Noelin-1
and -2 expression parallels other signs of neuronal differen-
tiation such as axon extension. Onset of Noelin-1 and -2
expression in the cranial ganglia correlates with the timing
of the first detectable differentiation of neurons in these
regions (see Schlosser and Northcutt, 2000). Migrating
ganglion cells can be identified just preceding the onset of
Noelin expression in the VIIth, IXth, and Xth (epibranchial)
ganglia, and neurite extension occurs when Noelin is highly
expressed in these regions. In contrast, expression in the Vth
ganglion (trigeminal) is concurrent with the first appear-
ance of ganglionic cells. Since the time of origin and the
location of the profundal-trigeminal placode is separate
from that of the epibranchial placodes (termed the dorsolat-
eral placode area by Schlosser and Northcutt), it is likely
that the difference in timing of Noelin-1 and -2 expression
among these ganglia reflects differences innate to the early
placodal domains.
Xenopus Noelin-1 and -2 are not expressed in early neural
tissues, or in premigratory or migrating neural crest (at least
until late stages in the fin). The later expression pattern of
avian Noelins corresponds to the Xenopus pattern, with the
exception of the migrating neural crest cells that are posi-
tive in the chick. Additionally, in Xenopus, neither
Noelin-1 nor Noelin-2 marks placodal ectoderm as is the
© 2001 Elsevier Science. Acase in the chick, nor do they display distinct distribution
in placodal versus neural crest cell types. These differences
in Noelin isoform expression between two species may
indicate that the role of Noelin-1 is not to promote neural
crest or neural development in particular, but to participate
in neuronal differentiation in general during nervous sys-
tem development. Alternatively, the varying expression
patterns and functions of Noelin-1 could indicate that the
same isoform has different developmental roles in different
species, or that avian embryos may have an added function
in neural crest generation. Whether avian Noelin-1 can
promote neurogenesis as does the Xenopus homolog has not
yet been examined.
Xenopus Noelin Expression in Cranial Ganglia
Xenopus cranial neural crest consists of two physically
separate populations of cells; the early migrating cranial
masses (lateral neural crest) that generally underlie the
placodal ectoderm, and a later-migrating population of
neural crest cells in the neural folds (medial neural crest;
see Sadaghiani and Thiebaud, 1987; Schlosser and North-
cutt, 2000). In amniotes, the cranial sensory ganglia consist
of proximal and distal lobes, with neural crest cells making
up the proximal ganglia and placode cells making up the
distal (Baker and Bronner-Fraser, 2001). In contrast, in
Xenopus embryos, proximal and distal regions of the cranial
ganglia are fused (Schlosser and Northcutt, 2000). Thus, it is
not possible to describe ganglion cells as crest- or placode-
derived based on their positions in the Xenopus embryo.
Therefore, we labeled premigratory medial neural crest
cells to determine whether they contributed to the Noelin-1
and -2-expressing cells in the ganglia.
DiI labeling experiments show that Noelin-1 and -2 are
not expressed by the late (medial) neural crest in the cranial
ganglia. Medial neural crest cells migrate to the areas
surrounding the cranial ganglia but do not enter, rather they
remain in proximity and are distinguishable by their posi-
tions approximating the ganglia. These later-migrating neu-
ral crest cells do not express Noelin-1 and -2, and do not
appear to enter the cranial ganglia until after stage 33/34.
Since Noelin-1 and -2 expression in the cranial ganglia
appears fairly uniform at all stages including stages after
those that were addressed in the DiI labeling experiments,
it is likely that neural crest cells entering the ganglia
up-regulate Noelin-1 and -2 expression once they reach
their destination, and that the ganglion cells expressing
Noelin-1 and–2 are placode-derived. Perhaps an autoregula-
tory loop exists in which neural crest cells that enter the
ganglia and contact Noelin-1 and -2-positive cells (ganglion
cells) are induced to begin transcribing the gene themselves
and begin neuronal differentiation. Although Noelin-1 was
not able to induce its own expression in whole embryos, it
is possible that in the correct context (e.g., presence or
balance of cofactors) this mechanism could operate. This
idea is supported by the extracellular localization of Noelin
ll rights reserved.
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naling to occur.
Regulation of Noelin
Over-expression of X-ngnr-1 and XNeuroD causes prema-
ture and ectopic neuronal differentiation (Lee et al., 1995;
Ma et al., 1996). These genes also activate Noelin-1 and -2
expression. In whole embryos, both isoforms are induced in
ectopic neurons induced by expression of these genes. It has
been shown that the character of neurons induced by
X-ngnr-1 is sensory in nature (Olson et al., 1998; Perron et
al., 1999); accordingly, neurons induced by X-ngnr-1 do not
express the interneuron marker Pax-2 (Heller and Brandli,
1997). It is likely that Noelin-1 and -2 expression in these
ectopic neurons represents a subclass of sensory type,
perhaps similar neurons generated in the cranial ganglia.
Additionally, regions of the increased neural tissue in the
head induced by X-ngnr-1 and XNeuroD also express
Noelin-1 and -2. N-tubulin, among many other markers of
neuronal differentiation, is induced in the head regions of
embryos injected with these genes. However, the transcrip-
tion factor Pax-6 is down-regulated in tissues that would
normally express it (Hirsch and Harris, 1997). Thus, genes
that may be responsible for patterning neural tissue are
down-regulated in favor of neuronal differentiation mark-
ers. Because Noelin-1 and -2 expression is induced in the
tissue regions and cells that are undergoing differentiation,
a role in neuronal differentiation is further supported.
Noelin-1 is weakly induced in a more direct test of the
effect of neurogenic genes in animal cap explants. XNeuroD
and X-ngnr-1 also promote neuronal differentiation in ani-
mal caps, in the absence of mesodermally mediated neural
induction. Because Noelin-1 and -2 up-regulation in whole
embryos expressing the same neurogenic genes is much
more robust, it seems likely that the expression of Noelin-1
and -2 requires other signals, either as a result of neural
induction or from surrounding tissues that may supply
necessary cofactors for their expression.
Function of Noelin
Experiments designed to test the functional capabilities
of Noelin-1 in the chick show that it can affect neural crest
development. Alone, neither Xenopus Noelin-1 nor -2 de-
tectably affected neural or neural crest development when
overexpressed in whole embryos. This lack of effect was not
due to protein degradation, since the myc-tagged protein,
which was assumed to correlate with exogenous Noelin-1
expression, persisted at least through stage 25 as assessed by
myc-immunoreactivity. It is possible that cells possess
regulatory factors that control the response to exogenous
Noelin-1 and -2. Alternatively, it is also possible that
increasing Noelin-1 and -2 expression has no effect unless
levels of another cofactor are also increased. Cofactor re-
quirements have been shown for other genes; for example
the proneural gene XASH-3 promotes neurogenesis much
© 2001 Elsevier Science. Amore efficiently in the presence of its binding partner XE12.
Further, XASH-3 plus XE12 activate stable neurogenesis
only when expressed in Noggin-treated tissue; otherwise,
the effect is transient (Ferreiro et al., 1994).
In neuralized animal cap explants, Noelin-1 promotes
neurogenesis, causing neuronal differentiation markers to
be expressed earlier than in neuralized caps alone. By
RT-PCR and in situ hybridization, SybII and N-tubulin are
induced by stage 24 in animal cap explants co-injected with
Noelin-1 and noggin, while in noggin-injected animal caps,
these markers are not expressed until around stage 33. One
way to explain the early differentiation in the explants is
that the tissue could have been posteriorized, since neuro-
nal differentiation occurs much earlier in more caudal
regions of the embryo. Our results show that posterioriza-
tion was not the mechanism for inducing early differentia-
tion, since Noelin-1 1 noggin did not activate the more
posterior neural markers En-2, Krox-20, orHoxB9. Further,
the induced neurons in Noelin-1 1 noggin injected animal
caps are likely to be of sensory character, since XBrn-3d was
upregulated. Accordingly, it seems likely that endog-
enously Noelin-1 plays a role in promoting neuronal fate,
since in whole embryos it is expressed in developing neu-
rons and it can accelerate neurogenesis in neuralized ani-
mal caps.
In addition to promoting neuronal differentiation in neu-
ralized animal caps, our results show that Noelin-1 itself
has limited neural inducing properties. Noelin-1 expression
alone induced XBrn-3d, Krox-20, and XNeuroD, without
inducing NCAM expression. Interestingly, it appears that
the secreted form of the protein is required for induction of
the sensory marker XBrn-3d and XNeuroD, while both
secreted and ER-localized forms could induce early differ-
entiation (SybII) and expression of Krox-20. This indicates
that the protein may have different functions depending on
whether it is outside or inside the cell; inside the cell it
functioned to promote general differentiation, when it was
secreted it could also direct upregulation of subtype-specific
neural markers that in the embryo are expressed before
differentiation. The induction of Krox-20 by all three
Noelin-1 constructs suggests that it is activated by an
intracellular Noelin-1, since our oocyte secretion assay
showed that the secreted forms also are abundantly present
inside the cell. Thus cellular localization may play an
important role in determining the capability of Noelin-1 to
promote differentiation or fate choices in developing neu-
rons.
Interestingly, in whole animal caps, N-tubulin activation
in noggin 1 Noelin-1 samples was not found throughout
the explants; rather it was confined to small areas with
scattered cells. A similar pattern of neurogenesis was found
in animal caps expressing noggin 1 Noradrenaline, where
this neurotransmitter caused induction of neuronal differ-
entiation in neuralized animal caps (Messenger et al., 1999).
This could be due to mosaic inheritance or uneven distri-
bution of the injected mRNAs. Alternatively, the effect
could be reminiscent of a pre-existing pattern of gene
ll rights reserved.
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ciliated epidermal cells in Xenopus is regulated by the
Notch-Delta lateral inhibition pathway in which certain
cells take up the fate of ciliated epidermis, thereby prevent-
FIG. 7. Neurogenin induces Noelin-1 and –2 expression. Embryos
Noelin-2 upregulation is represented by expression of the A exon
results are identical to those performed for the Z exon, and result
from the same injection experiment, with anterior to the right. A
embryo probed for the A exon shows induced Noelin-2 expression
staining for the A exon in the head (arrowhead). B: Sibling injected e
C: Sibling embryo stained with N-tubulin shows massive ectopi
N-tubulin staining as compared to embryos in (A) and (B). Extra
sectioned at 12 microns. Embryos were injected with X-ngnr-1 or b
9 and cultured to stage 24. In situs were performed for N-tubulin o
and -2. D: Noelin-1 and -2 are upregulated weakly in animal caps
stained with N-tubulin show robust activation of expression (arrow
of Noelin expression in the absence of X-ngnr-1. G: Control animal c
of eye, usually malformed or absent in injected embryos.ing neighboring cells from acquiring that fate (Deblandre et
© 2001 Elsevier Science. Aal., 1999). Activation of N-tubulin expression in this punc-
tate manner could reflect this pre-existing expression of
lateral inhibition machinery in the ectoderm, such that
Noelin-1 could prompt cells expressing these genes (that are
cted with 100 pg X-ngnr-1 make ectopic neurons in the epidermis.
oelin-1 is represented by expression of the B exon. These in situ
identical for X-ngnr-1 and XNeuroD. Embryos shown are siblings
elin-2 is upregulated robustly in X-ngnr-1 injected embryos. An
ctopic neurons (for example, see white arrow). Also note ectopic
o stained for the B exon. Ectopic neurons (arrow) express Noelin-1.
uction of neurons in the epidermis (arrow). Note the extent of
tissue is positive for N-tubulin (arrowhead). D-G: Animal caps
ctosidase (control) at the 2-cell stage, caps were collected at stage
separate Noelin exons, the Z pattern is representative of Noelin-1
mpared to the results in whole embryos (arrows). E: Animal caps
: Control animal cap stained with the Z exon shows no induction
ained with N-tubulin also fails to express this gene. e, shows regioninje
and N
s are
: No
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mbry
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head
-gala
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as co
s). F
ap stalso involved in neuronal selection) to be more receptive to
ll rights reserved.
357Xenopus Noelin-1 Promotes Neurogenesisbecome neurons and thus make a fate decision and express
N-tubulin.
Together, these results suggest that although Noelin-1
expression is not sufficient to cause general neural induc-
tion as indicated by induction of NCAM, perhaps it may
participate in a signaling pathway as a factor to promote or
maintain a neuronal differentiation program. This is sug-
gested by its ability to induce expression of later neural
markers such as XBrn-3d, XNeuroD, and Krox-20, and by its
failure to posteriorize noggin-induced neural tissue. Alter-
natively, it could be that the differentiation-promoting
property of Noelin-1 in noggin-treated explants is separate
from its ability to induce Krox-20 on its own, as the ability
of noggin to induce neural tissue of forebrain character
could not be altered to a more posterior fate (to express
Krox-20) by Noelin-1; in fact, noggin co-expression re-
pressed the Noelin-1-mediated induction of Krox-20 in
FIG. 8. Noelin-1 promotes neurogenesis in neuralized tissue. An
stage with 100 pg noggin, 500 pg Noelin-1, or both. The explant
performed against N-tubulin. A: Animal caps injected with Noelin
do not express N-tubulin. (Diffuse purple color is due to trapping o
C: Animal caps co-injected with noggin and Noelin-1 upregulate N
At stage 24, a smaller proportion of the explants express N-tubuli
14/17 explants express N-tubulin to varying degrees. In some cases
explant (arrowheads); the majority of explants with induced N-tu
explants (arrows).explants. Our results in Xenopus explants may also indicate
© 2001 Elsevier Science. Athat Noelin-1 has divergent or added functions in neural
development among vertebrate species, since avian
Noelin-1 affects neural crest development while Xenopus
Noelin-1 did not. However, the possible role of Noelin-1 in
avian neurogenesis has not yet been tested.
In conclusion, we find that Xenopus Noelin-1 is an
evolutionarily conserved protein by sequence and protein
structure, but that its expression pattern and function are
considerably different in Xenopus and avian embryos dur-
ing early development. Its differing roles in neural crest
formation in the chick and neurogenesis in Xenopus, and
the dependence of its inductive abilities on its localization,
may indicate that it functions in multiple mechanisms of
neural development. Future work will address how
Noelin-1 exerts its neural effects, whether other Noelin
isoforms in Xenopus have been co-opted for a function
similar to that in chick, and with what partners Noelin may
caps were collected at stage 9 from embryos injected at the 2-cell
re cultured to stage 27. Whole mount in situ hybridization was
ne do not express N-tubulin. B: Animal caps injected with noggin
tion components inside animal cap cavities, see black arrowhead.)
ulin by stage 24 (caps shown in this figure were fixed at stage 27).
6, data not shown). In the representative experiment shown here,
ngly positive N-tubulin regions were confined to small areas of the
expression show positive cells scattered through regions of theimal
s we
-1 alo
f reac
-tub
n (3/
, stro
bulininteract in the developing embryo.
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